Skip to content

Stock-Based Comp at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$83M+10.7%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$10.7M-7.8%
Revvity logo
RevvityRVTY
$8.72M+12.7%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$1.12M+14.7%
Agilent Technologies logo
Agilent TechnologiesA
$32M+6.7%
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$4.46M-51.5%

Other financials

Income statement

See full
Revenue$36.4M+20.1%
Gross profit$15.6M+4.9%
Operating income-$41.4M-56.9%
Net income-$17.5M+14.5%
EPS (diluted)-$0.37+30.2%

Balance sheet

See full
Cash & equivalents$36.2M-52.7%
Total debt$35.3M-2.9%
Total equity$282.1M-10.8%
Total assets$366.7M-7.5%

Cash flow

See full
Operating cash flow-$18.1M-30.4%
CapEx$87.0K-93.1%
Free cash flow-$18.2M-20.1%

Valuation

See full
Market cap$203.97M-20.1%
Enterprise value$203.12M+28.6%
P/S1.4×-0.6×

Profitability

See full
Gross margin44.2%-14.3pp
Operating margin-96.9%-1,691pp
Net margin-71.9%-2,019pp
FCF margin-57.2%-220pp

Returns & leverage

See full
Return on equity-34.8%-122pp
Debt / equity0.1×0.0×
Current ratio3.7×-4.6×

Where this comes from

Reported directly by Quanterix Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Quanterix Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quanterix Corporation's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Quanterix Corporation's stock-based comp?
Quanterix Corporation (QTRX) reported stock-based comp of $4.53M in Q1 2026.
How has Quanterix Corporation's stock-based comp changed year-over-year?
Quanterix Corporation's stock-based comp decreased by 17.1% year-over-year, from $5.46M to $4.53M.
What is the long-term trend for Quanterix Corporation's stock-based comp?
Over 4 years (2021 to 2025), Quanterix Corporation's stock-based comp has grown at a 6.7% compound annual growth rate (CAGR), from $15.98M to $20.72M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.